Research on Corporate Governance of Medical Care Corporate Corporation-Case Study of Chang Gung,MacKay,Kaohsiung Medical University and Taipei Medical University

• Main Authors: Tsan Chang, 張璨
• Other Authors: Ben-Chang Shia
• Format: Others
• Language: zh-TW
• Published: 2018
• Online Access: http://ndltd.ncl.edu.tw/handle/d98t4g

碩士 === 臺北醫學大學 === 管理學院生物科技高階管理碩士在職專班 === 106 === Abstract The number of Taiwan medical foundation is only 11% of the whole hospital, but the net value is about 500 billion, the number of sick beds is 32%, and the medical expense accounts for nearly 41%. Therefore, the management of medical foundation is very important to all the people. Taiwan''s Medical Care Act legislation is to promote the sound development of medical services, to distribute medical resources rationally, to improve medical quality, to protect the rights and interests of the patients and to improve the health of the people. After the April 2004 Revision of the law, medical institutions added the type of “Medical Incorporation". Since the hospital, in general, divided into public, private medical institutions, medical legal persons (Medical Foundation and Medical Incorporation). Among them, the legal system of medical consortium under the reform of Medical Act is becoming more and more obscure in the process of the National Health Insurance payment system, the limited source of funds and the process of the group development, and the law (Medical Act) is insufficient in the management and supervision of the medical consortium, resulting in medical treatment. The corporate malpractices and scandals of the consortium have been heard, such as holding a large number of funds on a large amount of health insurance with its operating advantages, and enjoying various tax cuts for the public welfare of the consortium medical legal person, but there are many problems in the financial report. When a medical consortium is often a particular group (family, business or religion) to control the money making, it is easy to deal with the dealing with the affiliate and the hollowing out of the company. This paper, based on the recent cases of the representative medical consortium of Taiwan, discusses the process of the evolution of the hospital company, the system and principles of its corporate governance, how to introduce the Committee of the patient''s safety and medical quality into the framework of the board of directors, and further consider how to give consideration to the international competitiveness of the hospital in the age of AI. The balance between medical quality and patient safety, interests of stakeholders and shareholders, implementation of supervision and management of the board of supervisors and disclosure of financial information.